Hemostastic embolization in oncology

Revel-Mouroz, Paul; Mokrane, Fatima-Zohra; Collot, S.; Chabbert, V.; Rousseau, Hervé; Otal, P.

doi:10.1016/j.diii.2015.06.008

Cited by 14 publications

(11 citation statements)

References 59 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…TAE is today recommended in a variety of haemorrhagic conditions such as trauma, haemoptysis, tumors, etc. (Coccolini et al 2017;Spiliopoulos et al 2018;Chun et al 2010;Revel-Mouroz et al 2015;Chakraverty et al 2012). Moreover, the continuously increasing population age, as well as the widespread use of more potent antithrombotic therapy has increased reports of severe spontaneous bleeding, while therapeutic anticoagulation at the time of bleeding, aggravates the severity of the event by triggering hemodynamic instability (Spiliopoulos et al 2019).…”

Section: Introductionmentioning

confidence: 99%

Multicenter retrospective study of transcatheter arterial embolisation for life-threatening haemorrhage in patients with uncorrected bleeding diathesis

et al. 2020

View full text Add to dashboard Cite

Background We retrospectively investigated outcomes of emergency TAE for the management of life-threatening haemorrhage in patients with uncorrected bleeding diathesis. Materials and methods This multicenter, retrospective, study, was designed to investigate the safety and efficacy of percutaneous TAE for the management of life-threatening haemorrhage in patients with uncorrected bleeding disorder at the time of embolization. All consecutive patients with uncorrected coagulation who underwent TAE for the treatment of haemorrhage, between January 1st and December 31th 2019 in three European centers were included. Inclusion criteria were thrombocytopenia (platelet count < 50,000/mL) and/or International Normalized Ratio (INR) ≥2.0, and/or activated partial thromboplastin time (aPTT) > 45 s, and/or a pre-existing underlying blood-clotting disorder such as factor VIII, Von Willebrand disease, hepatic cirrhosis with abnormal liver function tests. Primary outcome measures were technical success, rebleeding rate and clinical success. Secondary outcome measures included patients’ 30-day survival rate, and procedure-related complications. Results In total, 134 patients underwent TAE for bleeding control. A subgroup of 17 patients with 18 procedures [11 female, mean age 70.5 ± 15 years] which represent 12.7% of the total number of patients, presented with pathological coagulation parameters at the time of TAE (haemophilia n = 3, thrombocytopenia n = 1, cirrhosis n = 5, anticoagulants n = 7, secondary to bleeding n = 1) and were analyzed. Technical success was 100%, as in all procedures the bleeding site was detected and successfully embolised. Clinical success was 100%, as none of the patients died of bleeding during hospitalization, nor was surgically treated for bleeding relapse. Only one rebleeding case was noted (5.9%) that was successfully treated with a second TAE. No procedure-related complications were noted. According to Kaplan-Meier analysis the estimated 30-day survival rate was 84.2%. Conclusion TAE in selected patients with uncorrected bleeding diathesis should be considered as a suitable individualized management approach. Emergency TAE for life threatening haemorrhage in patients with coagulation cascade disorders should be used as an aid in realistic clinical decision making.

show abstract

Section: Introductionmentioning

confidence: 99%

Multicenter retrospective study of transcatheter arterial embolisation for life-threatening haemorrhage in patients with uncorrected bleeding diathesis

et al. 2020

View full text Add to dashboard Cite

show abstract

“…1 Massive hemoptysis can be life-threatening, with a mortality rate of more than 50% without adequate bleeding control. [2][3][4][5] Ninety percent of the source of massive hemoptysis comes from the bronchial circulation and 5% from the pulmonary circulation.…”

Section: Role Of Interventional Radiology In the Management Of Massiv...mentioning

confidence: 99%

“…[1][2][3] Hemoptysis occurs in 30% of patients with lung carcinoma, with 10% of them experiencing massive bleeding. [2][3][4][5][6][7] The severity of hemoptysis depends on several factors, such as history of disease, coagulation, and hemorrhagic shock. 4 Bronchial Artery Embolization (BAE) is a diagnostic and therapeutic procedure in interventional radiology that has an important role in cases of massive hemoptysis.…”

Section: Role Of Interventional Radiology In the Management Of Massiv...mentioning

confidence: 99%

Role of Interventional Radiology in the Management of Massive Hemoptysis

Sidipratomo

Sibarani

2021

J Respirol Indones

View full text Add to dashboard Cite

Massive hemoptysis is one of the emergencies in respiratory system, representing hemorrhage of the bronchial or pulmonary vascular system into the respiratory tract. Massive hemoptysis is a life-threatening condition due to high risk of asphyxia it may induce. Bronchial artery embolization (BAE) is an interventional radiology procedure dedicated in the emergency management of massive hemoptysis. BAE is known for its great success rate and low risk of complications. Proper catheterization technique, recognition of bronchial artery variant anatomy and appropriate selection of embolic material agent proves essential in determining the success of this procedure. As a minimally invasive procedure, BAE is highly recommended to be used in cases of massive hemoptysis.

show abstract

“…Similarly, embolization can be successfully used in ruptured HCCs, retroperitoneal tumors such as angiomyolipomas and renal cell carcinomas, and severe hemorrhagic cystitis (cyclophosphamide, RT induced) refractory to conservative management. [3435]…”

Section: Management Of Complicationsmentioning

confidence: 99%

Complementary role of intervention radiology in palliative care in oncology setting

Dhamija

Deshmukh

Meena

et al. 2019

Indian J Palliat Care

View full text Add to dashboard Cite

Owing to advances in treatment of cancer, there has been increase in life expectancy. Palliative care aims at improving quality of life of patients suffering from malignancy and is now recognized as a separate subspecialty. Management of cancer patients needs a multidisciplinary approach, and radiology has a key role to play at every step of it. Interventional radiology has broadened its scope immensely over the last decade with development of newer and less invasive applications useful in oncology and palliative care. The role of interventional radiologists begins from obtaining tissue for histopathological examination and extends to controlling disease spread with ablation or chemoembolization, to managing the tumor-related complications and relieving stressful symptoms such as dyspnea and pain. This article aims to review the interventional radiologist's arsenal in managing patients with malignancies with a special emphasis on palliative care, providing a more holistic approach in improving the quality of life of cancer patients.

show abstract

Hemostastic embolization in oncology

Cited by 14 publications

References 59 publications

Multicenter retrospective study of transcatheter arterial embolisation for life-threatening haemorrhage in patients with uncorrected bleeding diathesis

Multicenter retrospective study of transcatheter arterial embolisation for life-threatening haemorrhage in patients with uncorrected bleeding diathesis

Role of Interventional Radiology in the Management of Massive Hemoptysis

Complementary role of intervention radiology in palliative care in oncology setting

Contact Info

Product

Resources

About